 95% CI, 32.11-271.88 m) and
pain-free walking distance (89.76 m;
95% CI, 30.05-149.47 m), with no
signiÔ¨Åcant effect on ABI104
Tight glycemic control in patients with
type 2 diabetes reduced amputation
(RR, 0.65; 95% CI